General & Plastic Surgery Devices - New Zealand

In New Zealand, the General & Plastic Surgery Devices market market is forecasted to achieve a revenue of NZD US$63.56m by the year 2024.
It is anticipated that the revenue will experience a compound annual growth rate (CAGR 2024-2029) of 6.53%, leading to a market volume of NZD US$87.21m by 2029.
When compared globally, the United States is expected to generate the highest revenue in the market, with an estimated amount of US$9.84bn in 2024.
The demand for General & Plastic Surgery Devices in New Zealand is increasing due to the country's growing aging population and their desire for cosmetic enhancements.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in New Zealand is experiencing steady growth due to increasing customer preferences for cosmetic procedures, advancements in technology, and a growing elderly population. Customer preferences in New Zealand are shifting towards cosmetic procedures, driven by a desire for self-improvement and increased social acceptance of these procedures. This trend is similar to the global market, where there is a growing demand for aesthetic enhancements. In addition, the availability of a wide range of surgical and non-surgical procedures, such as breast augmentation, liposuction, and Botox injections, is attracting customers who are looking to enhance their appearance. The market is also benefiting from advancements in technology, which have made surgical procedures safer and more effective. New Zealand has access to state-of-the-art medical devices and equipment, allowing surgeons to perform procedures with greater precision and minimal invasiveness. These technological advancements have increased the overall satisfaction rate among patients and have contributed to the market growth. The aging population in New Zealand is another factor driving the growth of the General & Plastic Surgery Devices market. As the population ages, there is an increased demand for procedures such as facelifts, eyelid surgeries, and dermal fillers to combat the signs of aging. This trend is expected to continue in the coming years, as the elderly population continues to grow. Local special circumstances in New Zealand, such as the country's geographical location, can impact the market. New Zealand is a relatively small market compared to larger countries, which may limit the availability of certain devices and technologies. However, the country has a well-developed healthcare system and a high level of medical expertise, which attracts patients from both within New Zealand and from overseas. Underlying macroeconomic factors, such as GDP growth and disposable income levels, also play a role in the development of the General & Plastic Surgery Devices market in New Zealand. As the economy grows and disposable income levels increase, more individuals are able to afford cosmetic procedures. Additionally, medical tourism is becoming more prevalent, with patients from other countries seeking affordable and high-quality healthcare services in New Zealand. In conclusion, the General & Plastic Surgery Devices market in New Zealand is experiencing growth due to increasing customer preferences for cosmetic procedures, advancements in technology, a growing elderly population, and underlying macroeconomic factors. The market is expected to continue to expand in the coming years, driven by these factors and the ongoing demand for aesthetic enhancements.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.